August 3, 2017

New publication describes the development and clinical testing of ProteoMediX’ immunoassays for prostate cancer diagnosis

The development and technical validation of new immunoassays for ProteoMediX’ biomarker as well as the clinical testing were published in PLOS ONE. In conclusion, the report provides evidence that the newly developed method shows improved performance in diagnosing prostate cancer.